Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ("Tanabe Pharma", "MTPC" or "the Company") ...

U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...

Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.

Phase 3 Real Estate Partners and Bain Capital Real Estate have snagged a $484 million loan to refinance a 561,000-square-foot life sciences campus in Brisbane. The San Diego-based developer and ...

A joint venture between Phase 3 Real Estate Partners and Bain Capital Real Estate has sealed a $484 million loan to refinance a life sciences campus near San Francisco. “With attractive long-term ...

The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.

Bain Capital Private Equity proposed to buy the remaining shares of Surgery Partners, an ambulatory surgery center provider in which the private equity firm already has a 39% stake. Under the ...

US-based Bain Capital has increased its takeover bid for Australian wealth manager Insignia Financial to A$2.87bn ($1.76bn). The offer matches the indicative non-binding buyout offer made last ...

Jan 13 (Reuters) - Shares of Australia's Insignia Financial (IFL.AX), opens new tab hit a more than three-year high on Monday as a bidding war escalated, with private equity firm Bain Capital ...